IP Library › Granted Patent US 9,249,391
Granted Patent B2
US 9,249,391 · App. 14/335,246 · Granted Feb 2, 2016

Methods of generating neural stem cells

Inventors: Yadong Huang (San Francisco, CA); Karen Ring (San Francisco, CA)
Assignee: The J. David Gladstone Institutes
C12N5/0623C12N2501/11C12N2501/115C12N2501/602C12N2501/91C12N2502/99C12N2506/1307C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,249,391
App. No.
14/335,246
Granted
Feb 2, 2016
Kind
B2
Abstract

The present disclosure provides methods of generating neural stem cells from differentiated somatic cells. The present disclosure also provides induced neural stem cells generated using a subject method, as well as differentiated cells generated from a subject induced neural stem cell. A subject neural stem cell, as well as differentiated cells derived from a subject neural stem cell, is useful in various applications, which are also provided in the present disclosure.

Claims (10)

1. An isolated multipotent induced neural stem cell (iNSC) that is genetically modified with a nucleic acid comprising a nucleotide sequence encoding an exogenous Sox2 polypeptide, wherein the multipotent iNSC is not genetically modified with a nucleic acid comprising a nucleotide sequence encoding exogenous Oct-3/4, exogenous c-myc, exogenous Klf4, exogenous Nanog, or exogenous Lin28.

2. The multipotent iNSC of claim 1 , wherein the multipotent iNSC is derived from a human somatic cell.

3. A composition comprising the multipotent induced neural stem cell (iNSC) of claim 1 .

4. The composition of claim 3 , wherein the composition comprises a liquid culture medium.

5. The composition of claim 3 , wherein the composition comprises a cryopreservative agent.

6. The composition of claim 3 , wherein the composition comprises a matrix component.

7. The multipotent iNSC of claim 1 , wherein the multipotent iNSC is a human cell.

8. The multipotent iNSC of claim 1 , wherein the multipotent iNSC is a rodent cell.

9. The multipotent iNSC of claim 1 , wherein the Sox2 polypeptide comprises an amino acid sequence having at least about 80% amino acid identity to the amino acid sequence set forth in SEQ ID NO:1.

10. The multipotent iNSC of claim 1 , wherein the multipotent iNSC is capable of differentiating into a neuron, an astrocyte, or an oligodendrocyte.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2018
From: THE J. DAVID GLADSTONE INSTITUTES
To: THE J. DAVID GLADSTONE INSTITUTES; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 044578/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2014
From: HUANG, YADONG; RING, KAREN
To: THE J. DAVID GLADSTONE INSTITUTES
Reel/Frame 033948/0007 →
Continuity (4)
Division 13467475 · May 9, 2012
Continuation In Part PCTUS2010055836 · Nov 8, 2010
Provisional Application 61259885 · Nov 10, 2009
Related Publication 20150017139A1 · Jan 15, 2015